Drospirenone-EE 3-0.02 MG tab 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FP8YW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,117
Award facts
- Contract value 100% obligated
- $2,117.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,117.45 to AmerisourceBergen Drug Corp for the supply of Drospirenone-EE 3-0.02 mg tablets (28-count units) on January 27, 2026, with completion expected by January 28, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 vehicle that extends through December 2026 and serves as the primary procurement mechanism for pharmaceutical products and medical supplies supporting military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains, from generic medications to specialty pharmaceuticals and vaccines. This specific delivery order for hormone treatment medications reflects the company's ongoing role in supplying essential pharmaceutical commodities to military treatment facilities and federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FP8YW?
SPE2DR26FP8YW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FP8YW worth?
The government has obligated $2,117 on SPE2DR26FP8YW.
Is contract SPE2DR26FP8YW an order under another contract?
Yes. SPE2DR26FP8YW is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP8YW competed?
The extent of competition for SPE2DR26FP8YW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award